Liao Chun-Ta, Chang Joseph Tung-Chieh, Wang Hung-Ming, Ng Shu-Hang, Hsueh Chuen, Lee Li-Yu, Lin Chih-Hung, Chen I-How, Huang Shiang-Fu, Cheng Ann-Joy, See Lai-Chu, Yen Tzu-Chen
Department of Otorhinolaryngology, Head and Neck Surgery, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
Int J Radiat Oncol Biol Phys. 2008 Jun 1;71(2):371-6. doi: 10.1016/j.ijrobp.2007.10.015.
The criteria for administration of adjuvant radiation therapy (RT) in oral cavity squamous cell carcinoma (OSCC) remain controversial, and it is unclear whether patients with pT1-3N0 disease benefit from adjuvant radiation in the presence of free margins and perineural invasion. The goal of this report was to determine whether this group would benefit from adjuvant radiation therapy in terms of 5-year local control rate and overall survival rate.
We retrospectively reviewed our case records from January 1996 to May 2005. In all, 460 pT1-3N0 OSCC patients had tumor-free margins, of whom 68 had perineural invasion. Postoperative adjuvant RT was performed in patients with pT4 tumors, positive lymph nodes, or close margins (< or =4 mm). In addition, selected OSCC patients with large pT3 tumors or perineural invasion received postoperative adjuvant RT. Local control and overall survival rates were plotted by Kaplan-Meier analysis.
There were no significant differences in 5-year local control (p = 0.1936) and overall survival (p = 0.5580) rates between patients with perineural invasion compared with those without. Among patients with perineural invasion, the addition of adjuvant radiotherapy did not significantly alter the 5-year local control rate (p = 0.3170) or the overall survival rate (p = 0.0935).
Altogether, these data seem to indicate that radical surgical resection alone should be considered a sufficient treatment for OSCC patients with pT1-3N0 disease, even in the presence of perineural invasion.
口腔鳞状细胞癌(OSCC)辅助放疗(RT)的应用标准仍存在争议,目前尚不清楚pT1 - 3N0期疾病患者在切缘阴性且无神经侵犯的情况下是否能从辅助放疗中获益。本报告的目的是确定该组患者在5年局部控制率和总生存率方面是否能从辅助放疗中获益。
我们回顾性分析了1996年1月至2005年5月期间的病例记录。共有460例pT1 - 3N0期OSCC患者切缘阴性,其中68例有神经侵犯。pT4期肿瘤、淋巴结阳性或切缘阳性(≤4 mm)的患者接受术后辅助放疗。此外,部分pT3期大肿瘤或有神经侵犯的OSCC患者也接受了术后辅助放疗。采用Kaplan - Meier分析绘制局部控制率和总生存率曲线。
有神经侵犯的患者与无神经侵犯的患者在5年局部控制率(p = 0.1936)和总生存率(p = 0.5580)方面无显著差异。在有神经侵犯的患者中,辅助放疗的加入并未显著改变5年局部控制率(p = 0.3170)或总生存率(p = 0.0935)。
总体而言,这些数据似乎表明,对于pT1 - 3N0期OSCC患者,即使存在神经侵犯,单纯根治性手术切除也应被视为充分的治疗方法。